Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Treating central nervous system disorders through discovery, development, and commercialization of342K100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
U.S.342K100.00%